Author: Bill Snyder
Conn, Calipari to receive major pharmacology awards
Feb. 6, 2020—Two Vanderbilt University pharmacologists have won prestigious awards from the American Society for Pharmacology and Experimental Therapeutics (ASPET).
Carnahan named associate director of Vaccine Center
Feb. 6, 2020—Robert Carnahan, PhD, associate professor of Pediatrics and Radiology and Radiological Sciences, has been appointed associate director of the Vanderbilt Vaccine Center.
Genetics and EHRs
Feb. 6, 2020—Lisa Bastarache, MS, research assistant professor of Biomedical Informatics, and Tony Capra, PhD, associate professor of Biological Sciences and Biomedical Informatics, described the intersection of genetics and electronic health records during last week’s Cutting-Edge Discovery Lecture.
Team tracks integrin’s role in lung function
Feb. 6, 2020—Beta-1 integrin, a critical component of epithelial extracellular matrix receptors, is essential for normal lung function in adulthood, researchers at VUMC have discovered.
Nobel Prize-winning biochemist Stanley Cohen dies at 97
Feb. 6, 2020—Vanderbilt University biochemist Stanley Cohen, PhD, whose discovery of epidermal growth factor (EGF) and its receptor earned him a Nobel Prize and opened the door to a new class of cancer therapies, died Wednesday, Feb. 5, in Nashville. He was 97.
Vaccine Program receives NIH renewal of VTEU
Feb. 5, 2020—The Vanderbilt Vaccine Research Program has received a grant from the NIH to continue its work as one of the nation’s nine Vaccine and Treatment Evaluation Units.
Protein research seeks to induce tumor regression
Jan. 29, 2020—Understanding how MYC interacts with WDR5 and other cofactors could lead to the development of new drugs that can effectively block MYC and stop many cancers in their tracks.
Vaccine Program receives NIH renewal of VTEU
Jan. 23, 2020—The Vanderbilt Vaccine Research Program (VVRP) has received a grant from the National Institutes of Health (NIH) to continue its work as one of the nation’s nine Vaccine and Treatment Evaluation Units (VTEUs).
Antibody isolated at VUMC found to halt dengue virus
Jan. 23, 2020—Using part of an antibody isolated at Vanderbilt that “broadly neutralizes” the human dengue virus, biologists at the University of California San Diego and colleagues have disarmed the mosquito that transmits the disabling and potentially deadly tropical infection.
Wilkins named CTSA co-principal investigator
Jan. 16, 2020—Consuelo Wilkins, MD, MSCI, has joined Gordon Bernard, MD, as co-principal investigator of Vanderbilt’s Clinical and Translational Science Award.
VUMC study sheds light on gastric cancer development
Jan. 16, 2020—VUMC researchers have created the world’s first laboratory model of precancerous changes in the lining of the stomach, a scientific tour de force that is helping to unlock the mysteries of gastric cancer development.
Kavalali receives Humboldt Research Award
Dec. 31, 2019—Ege T. Kavalali, PhD, professor and acting chair of the Department of Pharmacology in the Vanderbilt University School of Medicine, has been elected a recipient of a prestigious Humboldt Research Award by the Alexander von Humboldt Foundation of Germany.
